Stryker Corporation – Consensus Indicates Potential 10.7% Upside
Stryker Corporation with ticker code (SYK) have now 21 analysts in total covering the stock. The consensus rating is ''Buy''. The target price ranges between 290 and 205 and has a mean target at 242.43. With the stocks previous close at 219.03 this would imply there is a potential upside of 10.7%. There is a 50 day moving average of 210.6 and the 200 moving average now moves to 246.6. The market cap for the company is $81,244m. Visit the company website at: https:||www.stryker.com [stock_market_widget type="chart" template="basic" color="green" assets="SYK" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $89,924m based on the market concensus. Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies.
Stryker Corporation – Consensus Indicates Potential 10.7% Upside
Stryker Corporation with ticker code (SYK) have now 21 analysts in total covering the stock. The consensus rating is ''Buy''. The target price ranges between 290 and 205 and has a mean target at 242.43. With the stocks previous close at 219.03 this would imply there is a potential upside of 10.7%. There is a 50 day moving average of 210.6 and the 200 moving average now moves to 246.6. The market cap for the company is $81,244m. Visit the company website at: https:||www.stryker.com [stock_market_widget type="chart" template="basic" color="green" assets="SYK" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $89,924m based on the market concensus. Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies.